Ready or not, genomics is coming to hospitals
This year, at a faster pace than many industry insiders anticipated, we're seeing genomics enter the world of real-life care for patients. It took researchers 13 years and about $3 billion to complete the Human Genome Project. A decade later, companies like Illumina (NASDAQ: ILMN) and Life Technologies (NASDAQ: LIFE) are in a fierce competition to sequence genomes at industrial scale, for as little as $1,000 apiece in a single day. But this year we are seeing an increasing wave of demand emerging from hospitals, clinics, and leading physicians who want to take advantage of the new fast and cheap sequencing tools to see if they can be used to help patients.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Hospitals Likely to Outsource ICD-10 at Launch
- IOM Identifies GME Problems, Calls for Finance Changes
- CMS Confirms ICD-10 Deadline
- Anatomy of 3 Health System Rebranding Efforts
- Premium Subsidy Fight Creating Uncertainty for Hospitals, Health Plans
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts